Medical Dermatology
Latest News
Think Beyond the ‘Go-Tos’ for Wart Management, Expert Advises
“Salicylic acid and cryotherapy don’t do enough for our patients,” said Jennifer Adams, MD.
Latest News
Nemolizumab Efficacy for Prurigo Nodularis Persists at 1 Year
The 52-week analysis included 307 patients on continuous nemolizumab and 174 patients randomized previously to placebo and were nemolizumab-naive...
Latest News
BTK Inhibitor Shows Promise for Hidradenitis Suppurativa
The novel drug is also under investigation in other immune-mediated inflammatory diseases, including chronic spontaneous urticaria and multiple...
Latest News
Study Links Maternal Hidradenitis Suppurativa to Risk for Childhood Morbidity
The study population included 1283 children whose mothers had HS and 1,274,310 unexposed children.
Latest News
Novel Agent Shows Promise for Hidradenitis Suppurativa
Longer-term phase 3 trials are planned to further examine the safety and efficacy of sonelokimab at the 120 mg dose.
Latest News
Flexibility Recommended for Patients With Personality Disorders
"You want to recognize the personality disorder, understand that there are underlying conflicts and needs, and adjust accordingly," Mio Nakamura,...
Latest News
Study Finds No Increased Cancer Risk With Spironolactone
Spironolactone, used off-label for several skin conditions in women, carries a warning about an increased tumor risk associated with high doses in...
Latest News
Patient-Reported Outcomes Predict Mortality in Cutaneous Chronic GVHD
Study findings are relevant to dermatologists in academic and transplant centers and the community who provide skin cancer screenings or other...
Latest News
Study Eyes Longer IV Ertapenem for Recalcitrant Hidradenitis Suppurativa
The mean treatment duration was 13.1 weeks and the mean posttherapy follow-up occurred after a mean of 7.8 weeks.
Latest News
What Skin Manifestations Are Associated With Pediatric IBD?
The most common noninfectious dermatologic condition among the 425 children and adolescents was acne, followed by eczema.
Latest News
Company Announces Regulatory Filing for Nemolizumab for Two Indications
The development comes on the heels of the phase III OLYMPIA trial program.